Literature DB >> 2731170

Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).

N Kida1, T Yoshimura, K Mori, K Hayashi.   

Abstract

We have recently identified human epidermal growth factor-like immunoreactive factor synthesized and secreted by human breast cancer cells (MCF-7) as a secretory protein encoded by the pS2 gene, the transcription of which is directly induced by estrogen. We demonstrated in this paper that synthesis and secretion of pS2 protein as well as pS2 mRNA were induced about 5-fold specifically by physiological concentrations of estrogen, which stimulated growth of the cells about 5-fold. Stimulative effects of estrogen on both cell growth and synthesis/secretion of pS2 protein were inhibited completely by actinomycin D, cycloheximide, and antiestrogen. However, the increase in DNA synthesis from 6 h after the start of treatment of the cells with estrogen preceded the increase in the amount of pS2 protein in the culture medium from 12 h after that. Furthermore purified pS2 protein did not stimulate DNA synthesis of the cells. These results suggest that induction of pS2 protein by estrogen is not involved in the growth-stimulating effect of estrogen in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731170

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Estrogen is increased in male cholangiocarcinoma patients' serum and stimulates invasion in cholangiocarcinoma cell lines in vitro.

Authors:  Taweewun Hunsawong; Ekapot Singsuksawat; Nuannapa In-chon; Watinee Chawengrattanachot; Chanitra Thuwajit; Banchob Sripa; Anucha Paupairoj; Siri Chau-in; Peti Thuwajit
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-03       Impact factor: 4.553

2.  Association of pS2 (TFF1) release with breast tumour proliferative rate: in vitro and in vivo studies.

Authors:  S J Reshkin; T Tedone; M Correale; A Mangia; V Casavola; A Paradiso
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

3.  Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.

Authors:  R S Rosenberg Zand; D J Jenkins; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  pS2 expression in primary breast carcinomas: relationship to clinical and histological features and survival.

Authors:  A D Thor; F C Koerner; S M Edgerton; W C Wood; M A Stracher; L H Schwartz
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Molecular aspects of restitution: functions of trefoil peptides.

Authors:  R Poulsom; D E Begos; I M Modlin
Journal:  Yale J Biol Med       Date:  1996 Mar-Apr

6.  Immunohistochemical determination of pS2 in invasive breast carcinomas: a study on 942 cases.

Authors:  I Soubeyran; J Wafflart; F Bonichon; I de Mascarel; M Trojani; M Durand; A Avril; J M Coindre
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

Review 7.  Aspects of the biology of regeneration and repair in the human gastrointestinal tract.

Authors:  N A Wright
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

Review 8.  scFv antibody: principles and clinical application.

Authors:  Zuhaida Asra Ahmad; Swee Keong Yeap; Abdul Manaf Ali; Wan Yong Ho; Noorjahan Banu Mohamed Alitheen; Muhajir Hamid
Journal:  Clin Dev Immunol       Date:  2012-03-15

9.  Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line.

Authors:  V Go; J Garey; M S Wolff; B G Pogo
Journal:  Environ Health Perspect       Date:  1999-03       Impact factor: 9.031

10.  Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells.

Authors:  P R Baker; J C Wilton; C E Jones; D J Stenzel; N Watson; G J Smith
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.